Table 2.
Summary of lung the US findings, lung US aeration score, and CT findings
| Patient | Severity | Lung US Daya |
Lung US main findings | Lung US score | CT Daya |
CT finding |
|---|---|---|---|---|---|---|
| 1 | Mild | Day 3 | Multiple well-defined B-lines in all the regions bilaterally; Confluent B-lines in the anterior and lateral bases and posterior upper right lobe; confluent B-lines on the lateral left base with pleural disruption | 15 | – | |
| 2 | Mild | Day 3 | Normal | 0 | – | |
| 3 | Critical | Day 5 | Consolidations > 0.5 cm in the anterior, lateral and posterior right lung, superior and inferior; Multiple confluent B-lines in the anterior base, lateral and posterior left lung with consolidation .0,5 cm in the posterior left base; Bilateral pleural effusion | 30 | Day 15 |
Foci of consolidation sometimes rounded, associated with multifocal ground-glass opacities seen bilaterally predominantly of peripheral distribution Small pleural effusion |
| 4 | Moderate | Day 5 | Posterior right upper lobe subpleural consolidation < 0.5 cm with confluent B-lines | 4 | Day 4 | Ground-glass opacity on the posterior right upper lobe |
| 5 | Mild | Day 3 | Normal | 0 | – | |
| 6 | Moderate | Day 2 | Normal | 0 | – | |
| 7 | Mild | Day 4 | Normal | 0 | – | |
| 8 | Mild | Day 4 | Multiple well-defined B-lines bilaterally. Confluent B-lines in posterior left lung with pleural disruption and subpleural consolidations < 0.5 cm | 12 | Day 6 | Multiple lung opacities and scarce foci of consolidation bilaterally, predominantly of peripheral distribution and in the left lower lobe |
| 9 | Critical | Day 7 |
Confluent B-lines on the lateral lung field bilaterally Consolidations > 0.5 cm of the posterior lung field bilaterally Bilateral pleural effusion |
20 | Day 7 |
Multiples ground-glass opacities, with interlobular septum thickening and multiple areas of consolidation, predominantly of peripheral distribution and in the posterior and inferior lung fields bilaterally Bilateral pleural effusion |
| 10 | Mild | Day 2 | Normal | 0 | – | |
| 11 | Mild | Day 2 | Normal | 0 | – | |
| 12 | Mild | Day 2 | Normal | 0 | Day 3 | Normal |
| 13 | Critical | Day 6 | Scarce multiple well-defined B-lines in the anterior and lateral right lung; confluent B-lines and subpleural consolidation in the posterior right lung. Confluent B-lines in the posterior left lung | 12 | Day 7 | Consolidation and centrilobular opacities with ground-glass attenuation in the upper and lower lobe of the right lung. Parenquimatous band in the left lower lobe |
| 14 | Moderate | Day 2 | Confluent B-lines in the posterior bases bilaterally, with < 0.5 cm subpleural consolidation | 4 | – | |
| 15 | Mild | Day 4 | Multiple well-defined B-lines in the right posterior upper lobe; Confluent B-lines in the posterior right lower lobe | 3 | – | |
| 16 | Mild | Day 4 | Multiple well-defined B-lines on the right lung and anterior left lung; Confluent B-lines on the lateral left base and posterior left lung | 15 | – | |
| 17 | Mild | Day 3 | Normal | 0 | – | |
| 18 | Mild | Day 3 | Multiple well-defined B-lines on the anterior bases bilaterally; Consolidation > 0.5 cm in the left upper posterior lung | 5 | – | |
| 19 | Moderate | Day 8 |
Multiple well-defined B-lines in the right lung Confluent B-lines and consolidation > 0.5 cm in the posterior left base |
8 | Day 14 | Parenquimatous band in the upper lobes and inferior left lobe, with a small consolidation on the left base |
| 20 | Mild | Day 4 | Normal | 0 | Day 5 | Normal |
| 21 | Mild | Day 1 | Normal | 0 | – | |
| 22 | Moderate | Day 2 | Confluent B-lines and < 0.5 cm subpleural consolidations in the right posterior upper and lower lung. Multiple well-defined B-lines and pleural disruption on the left lung, confluent B-lines on left lung base | 14 | Day 3 | Ground-glass opacities with consolidation and atelectasis bilaterally, more prominent in the right posterior upper and lower lung |
| 23 | Mild | Day 2 | Normal | 0 | – | |
| 24 | Mild | Day 7 | Normal | 0 | – | |
| 25 | Critical | Day 3 | Multiple well-defined B-lines in the lateral and posterior right lung; confluent B-lines on anterior upper right lung; Multiple well-defined B-lines on the left lung with consolidations > 0.5 cm in the lateral and posterior upper left lobe | 15 | – | |
| 26 | Moderate | Day 3 | Multiple well-defined B-lines in all the lung fields bilaterally | 12 | – | |
| 27 | Mild | Day 2 | Normal | 0 | – | |
| 28 | Moderate | Day 5 | Normal | 0 | ||
| 29 | Severe | Day 7 | Multiple well-defined B-lines in the anterior lung fields bilaterally. Confluent B-lines on posterior lung fields bilaterally and lateral right base; < 0.5 cm subpleural consolidations in the posterior right lung | 14 | Day 9 | Ground-glass opacities bilaterally; few small consolidations on the right lung, upper and inferior lobes |
| 30 | Severe | Day 5 | Confluent B-lines in the posterior upper right lobe | 2 | ||
| 31 | Mild | Day 4 | Normal | 0 | ||
| 32 | Moderate | Day 3 | Normal | 0 | ||
| 33 | Critical | Day 2 | Multifocal confluent B-lines and consolidations > 0.5 cm on posterior and lateral lung fields bilaterally | 20 | Day 3 | Multiple ground-glass opacities and scattered foci of consolidations, predominantly of peripheral distribution in the posterior lung fields bilaterally |
| 34 | Severe | Day 5 | Confluent B-lines and < 0.5 cm consolidations on anterior lateral and posterior lung fields bilaterally | 21 | Day 6 | Multiples ground-glass opacities, with interlobular septum thickening and multiple areas of consolidation, predominantly of peripheral distribution |
aTime elapsed, since the symptoms began